0.2066
전일 마감가:
$0.2215
열려 있는:
$0.227
하루 거래량:
2.38M
Relative Volume:
0.26
시가총액:
$20.79M
수익:
$69.49M
순이익/손실:
$-21.13M
주가수익비율:
-0.3183
EPS:
-0.649
순현금흐름:
$-14.46M
1주 성능:
+0.78%
1개월 성능:
+3.35%
6개월 성능:
-43.21%
1년 성능:
-75.44%
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health Inc
|
0.2066 | 21.39M | 69.49M | -21.13M | -14.46M | -0.649 |
|
MCK
Mckesson Corp
|
873.79 | 97.79B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
323.77 | 60.05B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
232.37 | 53.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
89.51 | 9.86B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
0.9431 | 873.84M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
Is Cosmos Health Inc (COSM) Undervalued After Q2 Earnings Miss? GF Score: 29/100, Revenue at $18.99 Million - GuruFocus
Cosmos Reports Record Q2: Revenue $19.0M, H1 $36.9M; Adjusted Gross Profit Up 58% - TradingView
Cosmos Health Company Profile & Introduction - Moomoo
COSM Looks 40.0% Undervalued on GF Value™ Amid Distribution Deal - GuruFocus
Cosmos Health signs exclusive Saudi distribution deal for supplements By Investing.com - Investing.com South Africa
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare - TradingView
Cosmos Health signs exclusive Saudi distribution deal for supplements - Investing.com
Cosmos Health Secures Exclusive Saudi Arabia Distribution Agreement for Sky Premium Life with Innova Healthcare - Quiver Quantitative
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term - NTB Kommunikasjon
COSM Looks 43.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
MSN Money - MSN
Cosmos (COSM) Latest Quarter: The EPS Result Is Below Expectation in the Reported Period; Closing Reaction: The Stock Loses 6.20% in the Current UpdateAdjusted Earnings Analysis - Vinanet
Cosmos Health reports record Q2 revenue of $19 million By Investing.com - Investing.com Nigeria
Cosmos Health reports record Q2 revenue of $19 million, up 29% - Investing.com Nigeria
Cosmos Health Q2 Results: EPS Misses Estimate, Sales Rise 29% YoY - scanx.trade
Cosmos Health Reports Q2 2026 - TradingView
Cosmos Health Reports Record Q2 and First-Half 2026 Revenue, Exceeds $75 Million Adjusted Annualized Run-Rate - Quiver Quantitative
BRIEF-Cosmos Health Q2 Gross Profit USD 1.51 Million - TradingView
Press Release: Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Progra - Moomoo
Cosmos Health Q2 Net Loss Widens to $5.4M on Revenue Decline - Minichart
Cosmos Health Inc. (COSM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Cosmos Health Inc. 2026: Revenue $18.99M, EPS ($0.1) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) grows revenue yet flags doubt about its future - Stock Titan
Cosmos Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Cosmos Health Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Price to earnings forward of Cosmos Health Inc – DUS:V67A - TradingView
Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cosmos Health (NASDAQ: COSM) CEO swaps $70K debt for 349,825 shares - Stock Titan
Form 4 Cosmos Health Inc. For: 30 July By Investing.com - Investing.com Canada
Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock - Stock Titan
Cosmos Health (NASDAQ: COSM) CEO swaps $140,000 debt for 766,284 new shares - Stock Titan
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels - The Manila Times
Cosmos Health Advances its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C And B2B Channels - marketscreener.com
Cosmos Health Advances Its Technology-Driven Transformation - GlobeNewswire
Cosmos Health develops subscription platform for health products By Investing.com - Investing.com Canada
Cosmos Health develops subscription platform for health products - Investing.com
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Inc (COSM) Cash Flow - TradingKey
Cosmos Health Inc (COSM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cosmos Health Inc (COSM) Income Statement - tradingkey.com
COSM|Cosmos Health Inc|Price:0.205|Chg%:+0.005 - TradingKey
Cosmos Health Inc (COSM) Institutional Confidence - TradingKey
Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cosmos Health Inc (COSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Daily Brief Health Care: Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Akeso, Mitesco Inc, Nagaileben, Repligen Corp, Scribe Therapeutics, Cosmos Health and more - Smartkarma
COSM|Cosmos Health Inc|Price:0.199|Chg%:-0.001 - TradingKey
Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cosmos Health Inc 주식 (COSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jul 29 '26 |
Buy |
0.18 |
766,284 |
140,000 |
14,248,092 |
| Terzis Georgios | Chief Financial Officer |
Jun 16 '26 |
Buy |
0.25 |
168,135 |
42,000 |
2,235,398 |
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
자본화:
|
볼륨(24시간):